News

Company has announced collaboration with microsoft for microsoft azure cloud platform and services to provide integrated genomic data management solutions in healthcare.

PRISM efficiently tests drug compounds in multiple cell lines simultaneously, accelerating discovery of targeted therapies in the service of precision medicine.

The release of data by DEFRA will create opportunities for new types of applications in agri-tech, says expert adviser.

Agena Bioscience (Agena) has announced its partnership to co-develop commercial tests with CapitalBio Technology (CapitalBio) for a variety of agricultural applications on the MassARRAY® System.

A study by J. William Harbour, M.D., Associate Director for Basic Research and leader of the Eye Cancer Site Disease Group at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, and colleagues details the discovery of a biomarker that puts patients at a higher risk for metastasis of uveal melanoma.

Onxeo acquires first-in-class, signal-interfering DNA molecule based on one of the most promising new approaches in cancer treatment.

Researchers systematically find molecules that help regulate and protect DNA.

New study shows a single biopsy could provide enough molecular information to guide individualized therapy for prostate cancer patients.

Researchers identify potential new treatment options for therapy-resistant prostate cancer.

Lower oxygen intake could be used to prevent mitochondrial diseases from forming.